Tert-Butyl Formate

Tert-Butyl Formate

SCHEMBL27618488

CC(C)(C)OC=O.Oc1ccc(C2=CCNCC2)cc1

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
QDPR P09417 3/20 0.67
HTR2C P28335 8/20 0.46
SIGMAR1 Q99720 2/20 0.46
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
NAMPT P43490 1/20 0.38
TGFBR1 P36897 1/20 0.36
ACVR1 Q04771 1/20 0.36
KCNH2 Q12809 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tert-Butyl Formate SCHEMBL27488580 0.86 HTR2C (0.46) QDPRHTR2CSIGMAR1
Tert-Butyl Formate SCHEMBL27488926 0.86 SIGMAR1 (0.67) QDPRHTR2CSIGMAR1
Tert-Butyl Formate SCHEMBL22471331 0.86 HTR2C (0.46) QDPRHTR2CSIGMAR1TGFBR1ACVR1
Tert-Butyl Formate SCHEMBL27724681 0.82 KHK (0.48) QDPRHTR2CSIGMAR1
SCHEMBL8380936 0.82 QDPR (1.00) QDPRHTR2CSIGMAR1ESR1ESR2
Tert-Butyl Formate SCHEMBL27984616 0.80 SIGMAR1 (0.42) QDPRHTR2CSIGMAR1TGFBR1ACVR1
Hydrochloric Acid SCHEMBL17455197 0.80 QDPR (0.96) QDPRHTR2CSIGMAR1ESR1ESR2
Tert-Butyl Formate SCHEMBL27892715 0.79 QDPR (0.40) QDPRHTR2CSIGMAR1TGFBR1ACVR1
Tert-Butyl Formate SCHEMBL28752854 0.78 HTR2C (0.49) QDPRHTR2CSIGMAR1
SCHEMBL15317711 0.71 HTR2C (0.59) QDPRHTR2CSIGMAR1TGFBR1ACVR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100562319-C 2-cyanopyrrole and pyrimidine and its pharmaceutical use NOVARTIS AG (CH) 2009-11-25 CN disclosed
CN-1756553-A 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof NOVARTIS AG (CH) 2006-04-05 CN disclosed